Page last updated: 2024-11-02

phenylbutazone and Fibrocartilaginous Dysplasia of Bone

phenylbutazone has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohrs, U1
Hauswaldt, C1
Hunstein, W1

Other Studies

1 other study available for phenylbutazone and Fibrocartilaginous Dysplasia of Bone

ArticleYear
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
    Blut, 1969, Volume: 19, Issue:7

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone

1969